- Home
- HLVX vs ORMP Comparison
HLVX vs ORMP Comparison
Compare HLVX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- ORMP
- Stock Information
- Founded
- HLVX 2020
- ORMP 2002
- Country
- HLVX United States
- ORMP United States
- Employees
- HLVX N/A
- ORMP N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- HLVX Health Care
- ORMP Health Care
- Exchange
- HLVX Nasdaq
- ORMP Nasdaq
- Market Cap
- HLVX 87.6M
- ORMP 94.2M
- IPO Year
- HLVX 2022
- ORMP N/A
- Fundamental
- Price
- HLVX $1.89
- ORMP $2.35
- Analyst Decision
- HLVX Hold
- ORMP Hold
- Analyst Count
- HLVX 5
- ORMP 1
- Target Price
- HLVX $2.33
- ORMP N/A
- AVG Volume (30 Days)
- HLVX 124.1K
- ORMP 93.6K
- Earning Date
- HLVX 11-07-2024
- ORMP 11-26-2024
- Dividend Yield
- HLVX N/A
- ORMP N/A
- EPS Growth
- HLVX N/A
- ORMP N/A
- EPS
- HLVX N/A
- ORMP 0.11
- Revenue
- HLVX N/A
- ORMP N/A
- Revenue This Year
- HLVX N/A
- ORMP N/A
- Revenue Next Year
- HLVX N/A
- ORMP N/A
- P/E Ratio
- HLVX N/A
- ORMP $21.20
- Revenue Growth
- HLVX N/A
- ORMP N/A
- 52 Week Low
- HLVX $1.55
- ORMP $2.00
- 52 Week High
- HLVX $20.22
- ORMP $3.67
- Technical
- Relative Strength Index (RSI)
- HLVX 50.42
- ORMP 46.29
- Support Level
- HLVX $1.80
- ORMP $2.27
- Resistance Level
- HLVX $2.02
- ORMP $2.42
- Average True Range (ATR)
- HLVX 0.08
- ORMP 0.08
- MACD
- HLVX 0.01
- ORMP -0.00
- Stochastic Oscillator
- HLVX 41.86
- ORMP 38.89
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.